Stellantis NV
STLA
4.61
0.00
0.00%
Stellantis NV
US · STLA
#1266 by market cap
Listed 1970
4.61
0.00
0.00%
Live - 5344 symbols - heartbeat 109s ago
· 2026-10-08 06:38
Pre-market
4.42
-4.12%
After-hours
4.62
+0.22%
Overnight
4.50
-2.39%
- Market cap
- 13.37B
- P/E (TTM)i
- -0.61
- P/Bi
- 0.19
- EPSi
- -8.68
- Div yieldi
- 0.00%
- 52W posi
- 4%
Reader sentiment
Are you bullish or bearish on STLA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.86, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.15% YoY
Margins
- Gross margin
- -1.38%
- Operating margin
- -14.48%
- Net margin
- -14.57%
Key ratios & quality
- Enterprise valuei
- 26.36B
- Altman Z-Scorei
- 0.86
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 110.41B | 58.99B | 47.66B | 149.42B | 179.59B | 189.54B | 156.88B | 153.51B |
| Gross profit | 15.40B | 12.37B | 9.41B | 29.48B | 35.27B | 38.14B | 20.52B | -2.12B |
| Selling & admin expenses | 7.32B | 4.92B | 3.92B | 9.13B | 8.98B | 9.54B | 9.30B | 8.97B |
| Research & development | 3.05B | 2.57B | 2.23B | 4.49B | 5.20B | 5.62B | 5.78B | 11.15B |
| Operating profit | 5.03B | 4.87B | 3.25B | 15.86B | 21.08B | 22.98B | 5.44B | -22.23B |
| Pretax profit | 4.11B | 3.53B | 2.92B | 15.13B | 19.51B | 22.42B | 4.03B | -26.61B |
| Tax | 778.00M | 548.00M | 504.00M | 1.91B | 2.73B | 3.79B | -1.49B | -4.27B |
| Net profit | 3.63B | 3.58B | 2.02B | 14.21B | 16.78B | 18.63B | 5.52B | -22.33B |
| Basic EPS | 2 | 2 | 1 | 5 | 5 | 6 | 2 | -8 |
| Diluted EPS | 2.30 | 1.95 | 1.34 | 4.51 | 5.31 | 5.94 | 1.84 | -7.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 35.81B | 38.45B | 37.20B | 42.01B | 38.13B | 43.48B |
| Gross profit | 3.63B | 2.37B | -- | -- | 4.43B | 4.77B |
| Selling & admin expenses | 2.35B | 1.83B | -- | -- | 2.30B | 2.48B |
| Research & development | 1.43B | 1.94B | -- | -- | 1.44B | 1.31B |
| Operating profit | -154.00M | -1.40B | -- | -- | 687.00M | 983.00M |
| Pretax profit | -413.00M | -2.46B | -- | -- | 538.00M | 500.00M |
| Tax | -26.00M | -588.00M | -- | -- | 161.00M | 207.00M |
| Net profit | -387.00M | -1.87B | -- | -- | 377.00M | 293.00M |
| Basic EPS | 0 | -1 | -- | -- | 0 | 0 |
| Diluted EPS | -0.13 | -0.65 | -- | -- | 0.14 | 0.07 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 38.29B | 34.93B | 37.53B | 74.80B | 84.78B | 91.52B | 81.58B | 80.54B |
| Cash & ST investments | 12.78B | 15.59B | 23.82B | 51.41B | 50.27B | 48.41B | 37.08B | 31.32B |
| Inventory | 10.56B | 9.53B | 5.37B | 11.16B | 17.09B | 21.20B | 20.86B | 22.15B |
| Total assets | 96.87B | 98.04B | 75.29B | 171.77B | 186.16B | 202.13B | 207.61B | 195.15B |
| Total current liabilities | 36.08B | 34.38B | 31.46B | 64.86B | 66.83B | 73.94B | 75.19B | 78.74B |
| Short-term debt | 5.86B | 4.88B | 2.64B | 10.96B | 7.68B | 9.46B | 12.20B | 14.12B |
| Long-term debt | 8.46B | 6.75B | 9.60B | 20.57B | 17.84B | 18.56B | 23.33B | 30.19B |
| Total liabilities | 71,970,000,000.00 | 69,369,000,000.00 | 51,412,000,000.00 | 115,459,000,000.00 | 113,774,000,000.00 | 120,008,000,000.00 | 125,492,000,000.00 | 141,152,000,000.00 |
| Total equity | 24.90B | 28.68B | 23.87B | 56.31B | 72.38B | 82.12B | 82.12B | 54.00B |
| Retained earnings | -- | -- | 22.14B | 52.78B | 66.78B | 80.93B | 77.32B | 53.27B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 80.52B | -- | 80.54B | 89.33B | 90.38B |
| Cash & ST investments | -- | 32.67B | -- | 31.32B | 32.73B | 34.43B |
| Inventory | -- | 21.81B | -- | 22.15B | 24.96B | 23.99B |
| Total assets | -- | 200.68B | -- | 195.15B | 207.42B | 213.42B |
| Total current liabilities | -- | 75.91B | -- | 78.74B | 86.34B | 87.19B |
| Short-term debt | -- | 13.29B | -- | 14.12B | 17.33B | 15.86B |
| Long-term debt | -- | 25.95B | -- | 30.19B | 28.93B | 34.50B |
| Total liabilities | -- | 127,161,000,000.00 | -- | 141,152,000,000.00 | 146,471,000,000.00 | 151,686,000,000.00 |
| Total equity | -- | 73.52B | -- | 54.00B | 60.95B | 61.74B |
| Retained earnings | -- | 73.22B | -- | 53.27B | 53.64B | 53.93B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 9.95B | 8.67B | 6.24B | 18.65B | 19.96B | 17.95B | 1.54B | -4.65B |
| Depreciation & amortization | 5.51B | 2.19B | 2.38B | 5.87B | 6.80B | 7.55B | 7.23B | 6.98B |
| Free cash flow | 4.56B | 5.00B | 3.29B | 8.53B | 10.95B | 7.76B | -9.53B | -13.79B |
| Dividends paid | -1.00M | -618.00M | 0 | -4.20B | -3.35B | -4.21B | -4.65B | -1.96B |
| Stock buybacks / issuance | -- | 5.00M | -161.00M | 243.00M | -883.00M | -2.34B | -2.90B | 49.00M |
| Ending cash balance | 12.45B | 17.83B | 22.89B | 49.63B | 46.43B | 43.67B | 34.10B | 30.15B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.85B | 559.00M | -- | -- | -2.72B | -169.00M |
| Depreciation & amortization | 1.88B | 1.70B | -- | -- | 1.57B | 1.60B |
| Free cash flow | -5.50B | -1.94B | -- | -- | -4.35B | -1.63B |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 32.78B | 30.66B | -- | -- | 31.95B | 33.70B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 15.85 | 24.88 | 0.11 | 34.79 | 26.27 | 24.20 | 6.70 | -33.08 |
| ROA %i | 3.74 | 6.79 | 0.03 | 10.46 | 9.39 | 9.58 | 2.67 | -11.11 |
| ROIC %i | 11.25 | 17.93 | 1.41 | 21.57 | 17.92 | 16.62 | 4.45 | -20.28 |
| 5-year avg ROE %i | 10.11 | 11.51 | 12.82 | 18.17 | 19.93 | 21.60 | 20.54 | 12.18 |
| EBIT margin %i | 4.81 | 4.80 | 2.61 | 10.15 | 11.38 | 12.53 | 3.54 | -16.37 |
| FCF / sales %i | 4.13 | 1.92 | 0.67 | 5.71 | 6.09 | 6.49 | -- | -- |
| Current ratioi | 1.06 | 1.02 | 1.19 | 1.15 | 1.27 | 1.24 | 1.09 | 1.02 |
| Quick ratioi | 0.57 | 0.66 | 0.94 | 0.92 | 0.93 | 0.90 | 0.74 | 0.67 |
| Debt / assetsi | 15.00 | 13.16 | 18.20 | 19.55 | 14.59 | 14.58 | 17.93 | 23.54 |
| LT debt / equityi | 35.09 | 28.12 | 51.98 | 40.47 | 27.04 | 24.48 | 30.64 | 59.43 |
| Interest coveragei | 4.41 | 4.44 | 2.49 | 19.69 | 17.24 | 17.86 | 3.65 | -17.03 |
| Revenue CAGR (3Y) %i | -0.06 | -17.69 | -23.33 | 10.61 | 44.93 | 58.44 | 1.64 | -5.10 |
| Net income CAGR (3Y) %i | 121.06 | 21.09 | -14.62 | 57.88 | 73.78 | 104.54 | -27.23 | -- |
| FCF CAGR (3Y) %i | 69.72 | 28.56 | 13.01 | 23.26 | 29.84 | 33.11 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -3.09 | -- | -33.08 | -35.70 | -28.98 |
| ROA %i | -- | -1.17 | -- | -11.11 | -10.42 | -9.40 |
| ROIC %i | -- | -2.13 | -- | -20.28 | -19.58 | -16.69 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -3.01 | -- | -16.37 | -15.49 | -13.08 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | -- | 1.06 | -- | 1.02 | 1.03 | 1.04 |
| Quick ratioi | -- | 0.70 | -- | 0.67 | 0.68 | 0.68 |
| Debt / assetsi | -- | 20.33 | -- | 23.54 | 23.10 | 24.39 |
| LT debt / equityi | -- | 37.62 | -- | 59.43 | 50.54 | 59.08 |
| Interest coveragei | -- | -3.09 | -- | -17.03 | -15.92 | -12.76 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 06:38:32 · For reference only, not investment advice and not tailored to your situation.